Rice Hall James & Associates’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.18M Buy
138,840
+6,777
+5% +$244K 0.3% 84
2026
Q1
$4.25M Buy
132,063
+2,094
+2% +$74.4K 0.24% 92
2025
Q4
$4.68M Buy
129,969
+120,013
+1,205% +$4.41M 0.26% 87
2025
Q3
$313K Buy
+9,956
New +$357K 0.02% 240

Other funds holding VCEL

Rice Hall James & Associates's VCEL Position: Q2 2026 in Review

Rice Hall James & Associates increased its Vericel Corp (VCEL) stake by 5.1% in Q2 2026, buying an estimated $244K and bringing the position to 138,840 shares worth $6.18M. The position accounts for 0.3% of the portfolio, ranked #84.

Rice Hall James & Associates first reported a position in VCEL in Q3 2025 and has held it in 4 quarters since. 319 funds tracked by Wall St. Rank hold VCEL as of Q2 2026.

  • Rice Hall James & Associates held 138,840 shares of Vericel Corp worth $6.18M as of Q2 2026.
  • Rice Hall James & Associates bought 6,777 Vericel Corp shares in Q2 2026, an estimated $244K.
  • Vericel Corp made up 0.3% of Rice Hall James & Associates's portfolio in Q2 2026, its #84 holding.
  • Rice Hall James & Associates first reported a position in Vericel Corp in Q3 2025 and has held it in 4 quarters since.
  • 319 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2026.

Based on Rice Hall James & Associates's 13F filing for Q2 2026, filed 7 Aug 2026.